Visteon Balance Sheet Health
Financial Health criteria checks 5/6
Visteon has a total shareholder equity of $1.3B and total debt of $324.0M, which brings its debt-to-equity ratio to 25.5%. Its total assets and total liabilities are $2.9B and $1.6B respectively.
Key information
25.5%
Debt to equity ratio
US$324.00m
Debt
Interest coverage ratio | n/a |
Cash | US$550.00m |
Equity | US$1.27b |
Total liabilities | US$1.62b |
Total assets | US$2.89b |
Recent financial health updates
Here's Why Visteon (NASDAQ:VC) Can Manage Its Debt Responsibly
Aug 26Does Visteon (NASDAQ:VC) Have A Healthy Balance Sheet?
Apr 16Is Visteon (NASDAQ:VC) Using Too Much Debt?
Nov 30Is Visteon (NASDAQ:VC) A Risky Investment?
Aug 17Visteon (NASDAQ:VC) Has A Pretty Healthy Balance Sheet
May 19We Think Visteon (NASDAQ:VC) Can Stay On Top Of Its Debt
Feb 12Recent updates
Is Now An Opportune Moment To Examine Visteon Corporation (NASDAQ:VC)?
Dec 02Visteon Corporation's (NASDAQ:VC) Intrinsic Value Is Potentially 31% Above Its Share Price
Nov 12Little Excitement Around Visteon Corporation's (NASDAQ:VC) Earnings
Oct 22Returns At Visteon (NASDAQ:VC) Are On The Way Up
Sep 25Here's Why Visteon (NASDAQ:VC) Can Manage Its Debt Responsibly
Aug 26Estimating The Intrinsic Value Of Visteon Corporation (NASDAQ:VC)
Aug 11Visteon: Invest In EV And New-Age Electronics Growth
Jul 16Visteon Corporation's (NASDAQ:VC) Low P/E No Reason For Excitement
Jul 15When Should You Buy Visteon Corporation (NASDAQ:VC)?
Jun 15Shareholders May Not Be So Generous With Visteon Corporation's (NASDAQ:VC) CEO Compensation And Here's Why
May 31We Like These Underlying Return On Capital Trends At Visteon (NASDAQ:VC)
May 22Does Visteon (NASDAQ:VC) Have A Healthy Balance Sheet?
Apr 16What Does Visteon Corporation's (NASDAQ:VC) Share Price Indicate?
Mar 14Why Investors Shouldn't Be Surprised By Visteon Corporation's (NASDAQ:VC) P/E
Jan 30Visteon Corporation: Growth Through Ongoing Product Launches And Business Wins
Jan 30There's Been No Shortage Of Growth Recently For Visteon's (NASDAQ:VC) Returns On Capital
Dec 30Is It Too Late To Consider Buying Visteon Corporation (NASDAQ:VC)?
Dec 13Is Visteon (NASDAQ:VC) Using Too Much Debt?
Nov 30Estimating The Intrinsic Value Of Visteon Corporation (NASDAQ:VC)
Oct 18Does Visteon (NASDAQ:VC) Deserve A Spot On Your Watchlist?
Oct 05At US$139, Is It Time To Put Visteon Corporation (NASDAQ:VC) On Your Watch List?
Sep 01Is Visteon (NASDAQ:VC) A Risky Investment?
Aug 17Here's What To Make Of Visteon's (NASDAQ:VC) Decelerating Rates Of Return
Jul 23Here's Why We Think Visteon (NASDAQ:VC) Is Well Worth Watching
Jun 27Is Visteon Corporation (NASDAQ:VC) Trading At A 28% Discount?
Jun 03Visteon (NASDAQ:VC) Has A Pretty Healthy Balance Sheet
May 19Why Visteon Corporation (NASDAQ:VC) Could Be Worth Watching
May 07Returns On Capital At Visteon (NASDAQ:VC) Paint A Concerning Picture
Apr 24Here's Why We Think Visteon (NASDAQ:VC) Is Well Worth Watching
Mar 08Visteon Corporation (NASDAQ:VC) Shares Could Be 23% Above Their Intrinsic Value Estimate
Feb 24We Think Visteon (NASDAQ:VC) Can Stay On Top Of Its Debt
Feb 12Is Visteon Corporation (NASDAQ:VC) Potentially Undervalued?
Jan 27Visteon (NASDAQ:VC) Is Finding It Tricky To Allocate Its Capital
Jan 12Here's Why We Think Visteon (NASDAQ:VC) Is Well Worth Watching
Nov 22Calculating The Intrinsic Value Of Visteon Corporation (NASDAQ:VC)
Nov 09Here's Why Visteon (NASDAQ:VC) Can Manage Its Debt Responsibly
Oct 19Here's What's Concerning About Visteon's (NASDAQ:VC) Returns On Capital
Oct 06Is Now An Opportune Moment To Examine Visteon Corporation (NASDAQ:VC)?
Aug 11Calculating The Intrinsic Value Of Visteon Corporation (NASDAQ:VC)
Jul 29Visteon Q2 2022 Earnings Preview
Jul 27These 4 Measures Indicate That Visteon (NASDAQ:VC) Is Using Debt Reasonably Well
Jul 12Financial Position Analysis
Short Term Liabilities: VC's short term assets ($1.7B) exceed its short term liabilities ($937.0M).
Long Term Liabilities: VC's short term assets ($1.7B) exceed its long term liabilities ($683.0M).
Debt to Equity History and Analysis
Debt Level: VC has more cash than its total debt.
Reducing Debt: VC's debt to equity ratio has reduced from 67.6% to 25.5% over the past 5 years.
Debt Coverage: VC's debt is well covered by operating cash flow (99.4%).
Interest Coverage: Insufficient data to determine if VC's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:16 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Visteon Corporation is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Luke Junk | Baird |
Ishan Majumdar | Baptista Research |
Dan Levy | Barclays |